Barriers related to community, rights, gender and stigma (CRG) dimensions of TB care will be assessed among key population in Kazakhstan. At the 1st multi-stakeholders meeting, held in early October, representatives of NGOs, affected communities and public authorities, discussed and agreed on two key population groups (KPs), most relevant to be included in the qualitative study: people living with HIV and internal migrants, suffering or who suffered of TB. Respondents will be selected among representatives of these groups from rural and urban area of Almaty and Almaty region.
This multi-stakeholder meeting to identify the KPs was organized by the ALE “Kazakh Union of People Living with HIV” and is one of the main steps in the implementation of the CRG assessment. This round table in Kazakhstan was the first one conducted in the framework of TB-REP 2.0 and will be followed soon by similar ones in all countries that conduct this assessment.
The results will help countries in developing measures to remove the identified barriers and to move towards a more people-centred, human rights and gender-sensitive response to TB. This will ensure that TB services reach those groups who are currently deprived of it.
The round table participants also agreed on the methods for conducting the above assessment. They discussed the importance of desk review and related activities for understanding the country's context, public health priorities, trends and gaps in TB control.
The CRG assessment in Kazakhstan will be held by the “Kazakh Union of People Living with HIV” and is part of the of TB Regional EECA Project “Advancing people-centered quality TB care - From the New Model of Care Towards Improving DR-TB Early Detection and Treatment Outcomes” (ТB-REP 2.0 - implemented by the PAS Center during 2019-2021 in 11 partner countries: Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, Ukraine and Uzbekistan, with the financial assistance from the Global Fund). The overall goal of the program is to foster timely TB case detection and improved treatment outcomes in patients with special emphasis on drug-resistant TB, through meaningful involvement of communities and civil society and integrated people-centred TB care delivery systems able to address the needs of key and vulnerable populations.